South Korean chip stocks rose on Nov. 24, 2025, as U.S. market worries eased, while a new biopharm company surged on its debut.

South Korean chipmakers Samsung Electronics and SK hynix saw their stocks rise on November 24, 2025, as U.S. market concerns eased, with Samsung gaining 3.06% and SK hynix up 1.54%, recovering from steep Friday losses. The rebound followed stronger U.S. stock performance and reduced fears of a delayed Federal Reserve rate cut, though AI bubble concerns limited gains. Analysts attributed recent volatility to liquidity shifts, not fundamentals, supporting a buy-on-dips approach. Meanwhile, Samyang Biopharm, newly spun off from Samyang Holdings, surged 29.89% on its first trading day, hitting the daily limit at 30,200 won after a pure split that gave shareholders stakes in both companies.